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Abstract: Background: In the process of human reproduction, spermatogenesis is one of the most important stages,
which is controled by special genes on Y chromosome. Previous studies show that some infertile men have
microdeletions on Y chromosome, which cause the reduction of sperm count. Three prominent spermatogene-
sis loci have been identified on the Y chromosome and entitled “azoospermia factors” (AZFa, b, and c). Hereby,
this review article aimed to investigate the content of the Y chromosome microdeletions and their importance
in male fertility. Methods: Data and information were collected on English-language articles from PubMed
and MEDLINE databases. For Persian articles, Persian-language databases, including SID Scientific Database,
IranMedex Medical Articles Database, IranDoc (Iran Scientific Information and Documents Research Institute),
Magiran Publication Information, and MedLib were investigated. More than 50 articles on Y chromosome mi-
crodeletions and infertility published during 2000-2020 were studied. Results: Previous studies implicated that
Y chromosome microdeletions in AZFa, AZFb, and AZFc regions are accompanied by defect in spermatogenesis,
leading to oligo / azoospermia. Patients with AZFa and AZFb microdeletions present secretory azoospermia and
do not have sperm in their seminiferous tubules. Complete AZFc deletion involves region b2/b4, which con-
tains a total of 12 genes. Incomplete deletion of AZFc includes b1/b3, b2/b3 and gr/gr. The most common of
which are gr/gr. In men with gr/gr deletion, sperm count and motility were lower than control group. Conclu-
sion: Y chromosomal microdeletions emerged as the most frequent structural chromosome anomaly associated
with the quantitative reduction of sperm. The development of assisted reproductive techniques (ART) like intra-
cytoplasmic sperm injection (ICSI) and testicular sperm extraction (TESE) helps to bypass the natural barriers
of fertilization.
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1. Introduction
Infertility is an important worldwide problem. According
to the World Health Organization (WHO), if a couple does
not have children within a year of unprotected sexual activ-
ity, they become infertile. About 15% of young couples do
not have children in the first year and seek medical atten-
tion. One in eight couples in Europe needs help with their
first pregnancy (1). Most global statistics show that almost
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half of the cases of infertility are related to abnormalities in
sperm quality and quantity (2). In spermatozoa of infertile
men, there is an increase in aneuploidy, structural chromo-
somal abnormalities, and DNA damage. In 30-40% of infer-
tile men, there is no clear cause, and infertility may be caused
by various environmental pollutants, oxygen-free radicals,
and genetic and epigenetic abnormalities. The most impor-
tant reasons for male infertility are as follows: 1- Congeni-
tal or acquired abnormalities of the genitourinary system, 2-
malignancies, 3- Urogenital infections, 4- Scrotal fever (varic-
ocele), 5- Endocrine disorders, 6- Genetic abnormalities, and
7- Immunological causes.
In a study of 10469 infertile people with a variety of causes,
11.2% of them had azoospermia (3), which means they
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lacked sperm in their semen (4). The causes of azoosper-
mia can be classified as obstructive and non-obstructive. Ob-
structive azoospermia is defined as the absence of sperma-
tozoa in the ejaculate despite normal spermatogenesis be-
cause of problems in the transfer of the sperm from the testi-
cle to the ejaculatory duct of the urethra (5). Non-obstructive
azoospermia is a heterogeneous disorder in which the testis
cannot produce an adequate amount of sperm in the semen.
Factors affecting non-obstructive azoospermia include ge-
netic and environmental factors. The most important ge-
netic factors include inherited hypothalamic-pituitary disor-
ders, chromosomal abnormalities, microdeletions of the Y
chromosome, polymorphisms, and gene mutations (6-8).
The long and short arms of Y chromosome have many genes.
The region determining the male sex is located on the short
arm, while the genes effective in spermatogenesis are located
on the long arm. The identification and analysis of Y chromo-
some microdeletions (YCM) are very important for assess-
ing and studying male infertility (9-11). YCM in the Yq11 re-
gion are effective in male infertility. This region is known as
the azoospermia (AZF) region. The factors controlling sper-
matogenesis are located on the AZFa, AZFb, and AZFc on the
long arm of the Y chromosome (12) (Figure 1). The genes in
the AZF region code proteins that bind to RNA; these pro-
teins are involved in gene expression, RNA metabolism, cy-
toplasm transfer, and RNA splicing (8, 9, 13). Deletions that
occur in these areas can cause severe spermatogenic defects
such as oligospermia and azoospermia. The reason for these
deletions is the recombination between long bands of highly
repetitive DNA sequences during meiosis (14). Each AZF
region undergoes special stages in different stages of sper-
matogenesis (15, 16). Deletion of AZFa is associated with a
complete lack of reproductive cells and Sertoli cell syndrome.
Deletion of AZFb stops the growth of meiotic cells during the
clearance phase and leads to the cessation of meiosis. AZFc
deletions are associated with decreased sperm production
or cessation of sperm maturation associated with low sperm
count. Therefore, the deletions of any AZF region leads to
specific phenotypes (17). Specific deletion of a gene, has only
been reported in the AZFa region and belongs to the USP9Y
gene. These studies suggest that USP9Y is likely to be a "good
regulator" for sperm production (18). The highest frequency
of YCM are seen in men with azoospermia (8-12%) and oligo-
zoospermia (3-7%) (14). The most common AZF deletion is
related to AZFc with (65-70%) followed by YCM from AZFb,
AZFb+c, and AZFa+b+c (25-30%), and deletion of the AZFa
region is rare (5%) (14). Deletion of "gr/gr" results in the dele-
tion of half of the gene content. In the AZFc region, which in-
creases the oligozoospermia by 2.5-8 times, deletion of gr/gr
is a significant risk factor for impaired sperm production (19).
It is worth noting that its phenotypic expression vary in dif-
ferent ethnic groups, so that in some groups, it has no effect
on spermatogenesis (20). A significant proportion of sperm
from men with complete removal of AZFc is nullisomic for
chromosomes (21), which represents a potential risk for any
child to develop X0 45, Turner syndrome, and other phe-
notypic abnormalities associated with sex chromosome mo-
saicism, including ambiguous genitalia (21). Despite this
theoretical risk, infants born to fathers with Yq deletions are
phenotypically normal (22).This may be due to reduced im-
plantation rates and the possibility of spontaneous abortion
of embryos with a 45 X0 karyotype. When ICSI is used in the
presence of YCM, long-term follow-up of each baby boy is re-
quired according to their fertility status and sperm freezing at
a young age can be considered for them. Therefore, assessing
AZF deletions is important because it is possible that it would
be transferred to the child (boy), especially when assisted re-
productive technology (ART) is used (23).
Infertility and its individual and social problems are one of
the most important issues for couples, and this is significant
in that the cause of male infertility is detectable in only 40%
of cases and in 60% of cases is not pathologically detectable
(24).Therefore, infertility treatment is more difficult in men
than in women. According to studies conducted in other
countries and regions, it has been determined that the fac-
tors affecting male infertility are different in each region, and
it is of special importance to study the effects of each (25).
Currently, because of the widespread use of ART for infertile
people, the study of AZF deletions becomes more important
because the chances of transmitting deletions to the child in-
crease. Therefore, small YCM are recommended in infertile
patients with spermatogenesis defects, especially before the
application of intracytoplasmic sperm injection (ICSI). Be-
cause the finding of genetic factors leading to infertility not
only facilitates the transmission of genetic defects from par-
ents to the offspring but also because it can lead to more ex-
tensive offsprings, genetic studies can provide the necessary
information to the individual in the application of comple-
mentary methods for fertility. Therefore, studies to investi-
gate the effective causes of male infertility are very valuable.
In this study, the role of YCM in male fertility was investi-
gated.
2. Methods
For this study, as a narrative review, information on English-
language articles from PubMed and MEDLINE databases
were collected. For Persian articles, Persian-language
databases, including SID Scientific Database, IranMedex
Medical Articles Database, IranDoc (Iran Scientific Informa-
tion and Documents Research Institute), Magiran Publica-
tion Information, and MedLib were investigated. More than
50 articles on Y chromosome microdeletions and infertil-
ity published during 2000-2020 were studied. The keywords
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searched in this study were: microdeletion, Y chromosome,
DNA, sperm, and infertility. To select the documents, the ti-
tles of them were reviewed thematically using the search en-
gine. Then, the titles of the articles were evaluated in terms
of relevance to the subject and purpose and were studied
after selecting the appropriate items. Findings and results
which are related to the correlation between infertility in men
and YCM obtained from 50 articles studied were analyzed as
the main data of this study. The common results obtained
from previous studies and their inferences are mentioned as
part of the conclusion in this review article. In general, the
steps are included: searching for resources, selecting con-
tent, determining keywords, categorizing content, summa-
rizing, and concluding.
3. Results
3.1. The Prevalence of YCM
Previous studies revealed that the prevalence of YCM varies
from 5 to 15% in men with azoospermia and between 2 and
5% in men with Oligospermia. Of course, the prevalence
varies in different populations. Prevalence range is influ-
enced by multiple agents, for example: The type of diagnostic
method used can increase the number of false positive cases
and sometimes a partial YCM is considered as complete YCM
(26).
3.2. Types of YCM
The attendance of an obligatory spermatogenesis factor
called azoospermia factor (AZF) was identified preliminary
in 1976 from a de novo Yq deletions in azoospermia patients
(27). Deletions of the Y chromosome areas that possess the
AZF are discussed as the most common genetic imperfection
in male infertility (28).
Three frequently deleted non-overlapping sub-regions in
proximal, middle, and distal Yq11 were described and deter-
mined “AZFa,” “AZFb,” and “AZFc,” respectively.
The AZFa and AZFb regions are necessary in beginning of
spermatogenesis and the AZFc region is obligatory to com-
plete this process. The important AZFb interval is essential
for spermatocyte maturation. The AZFb locus is placed in the
central region of Yq11. The AZFc is placed at the distal part
of deletion interval 6 (subintervals 6C–6E) on the Y chromo-
some and is the most generally deleted zone of the AZF lo-
cus in infertile men. A special partial deletion of AZFc named
gr/gr deletion is remarkably correlated with male infertility
among Caucasians in Europe and the Western Pacific region
(29).
3.3. The consequences of YCM
3.3.1. Azoospermia
The European association of urology (EAU) guideline reports
a prevalence of microdeletion in men with azoospermia and
infertility is 8 to 12%. In most cases, azoospermia and infertil-
ity occur in men with complete elimination of AZFa/b/ (30).
Sperm extraction is almost always unsuccessful in these men,
they are infertile and unable to reproduce with their sperm.
The only choice for these patients is to use sperm or embryo
donation to have a child. Of course, in several cases, there
have been rare reports of sperm extraction from the testis in
AZFb or AZFb-c, but no clinical or chemical pregnancy re-
sulting from microinjection has been reported (31).
Complete deletion of AZFc may be associated with azoosper-
mia. In these men, microscopic surgery is found in up to 50%
of sperm cases and then used for microinjection (32).
3.3.2. Oligospermia
Preliminary Y chromosome microdeletion studies were di-
vided into two categories:
1- Severe oligospermia (zero to five million per ml)
2-Oligospermia (more than five million per ml) (33)
Recent EAU and American society for reproductive medicine
(ASRM) guidelines have reported a prevalence of early mi-
crodeletion in severe oligospermia of 3-7% and 5%, respec-
tively.
Both of these guidelines recommend screening men with
sperm counts less than five million per ml (7). Therefore, in
cases of severe oligospermia, in addition to karyotype test-
ing, AZF testing is required. Although YCM is present in
men with oligospermia with more than five million sperm
count, genetic testing is not recommended due to its high
cost and low prevalence. A meta-analysis of 12,492 patients
with oligospermia found that all cases of YCM occurred in
men with AZFc (26). Thus, only AZFc deletion can give de-
grees of oligospermia and sometimes azoospermia, but AZFa
and AZFb are associated with azoospermia only. In this study,
the prevalence of AZFc in men with oligospermia was 0-1
mil/ml (5%) higher than 1-5 mil/ml (0.8%), and it was also
higher than 5 mil/ml (0.5%).
Therefore, according to the above results, it can be concluded
that most men with AZFc (5.8%) are in the group of severe
oligospermia (less than 5 mill/ml) and it does not seem log-
ical that for men with oligospermia more than 1 mill/ml re-
quest AZFc. This is in contrast to the EAU guideline, which
recommends screening for AZF in men with severe oligosper-
mia less than 5 mill/ml.
In men with oligospermia due to AZFc deletion, there is a
possibility of natural fertility by the couple and it does not
seem to have an effect on the formed fetus (14). Also in
men with partial AZFb/AZFc, spermogram parameters may
be normal or sperm count may decrease but they might be
able to have normal fertility (34). At present, the data in
the literature do not show an increase in the incidence of
congenital anomalies or chromosomal abnormalities in off-
spring from Y chromosome microdeletion (34).
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3.4. Inheritance of AZF to the male newborn
The Y chromosome contains a male-specific region (MSY:
male specific region of Ychromosome) that is inherited from
father to son during meiosis. Men with AZFa and AZFb are of-
ten infertile because they have azoospermia, and most cases
of sperm extraction from the testicle fail, so there is no pos-
sibility of transmitting the disease to the son. Only if partial
deletion occurs in this area in oligospermic men there is a
possibility of transmitting the disease to the son (35).
Therefore, in men with incomplete AZFc deletion, it is rec-
ommended to undergo genetic counseling, and according to
the recommendation of a geneticist and the consent of the
couple, they can be candidates of ICSI with PGD. If they are
azoosperm, sperm can be retrieved from micro TESE, if they
have severe oligospermia in the semen itself, only the female
embryos can be transferred and therefore the transmission
of this microdeletion to male offspring will not occur. This
process diminish the miscarriage and transmission of chro-
mosomal microdeletion to the offspring, as well as prevent
possible defects in the formed fetus.
3.5. Reduction of progressive spermatogenesis
and the need for sperm freezing
Progressive reduction of sperm count has been shown in pa-
tients with AZFc deletion (28, 36). Sperm cryopreservation
in men with AZFc deletion in early adolescence is a rational
and practical choice for these individuals (34). The sperm
can survive for up to 15 years after freezing, so if sperms are
reduced or absent in patients with AZFcdeletion genetic dis-
order, frozen sperm can be used for ICSI.
3.6. YCM and ART outcome
Deletions of the AZFa, AZFb and AZFc regions are associated
with abnormal spermatogenesis and although certain dele-
tions have a detrimental effect on sperm retrieval, the ma-
jority of men with AZFc deletions have no problems during
sperm retrieval for use in ART. However, men with these dele-
tion(s) may optionally be subjected to further evaluations to
determine the extent of the effects of such deletions (37).
The method of ICSI combined with sperm retrieval tech-
niques such as testicular sperm extraction (TESE), can in-
crease the fertility rate in men with Y chromosome mi-
crodeletions.
Mulhall et al. (1997) compared eight azoospermic men with
AZFc deletions with 28 controls with normal Y chromosomes.
All patients were treated with TESE and subsequent ICSI.
While fertilization rates seemed to be lower in the AZFc dele-
tion group compared to controls (36 versus 45%), there was
no statistically significant difference. Pregnancy rates did
not differ between the two groups (38). Van Golde et al.
(2001) compared the success rate of 19 ICSI treatments in
eight couples with AZFc microdeletions to a control group of
239 ICSI treatments in 107 couples. Ejaculated spermatozoa
were used in both study groups. Although they found signif-
icantly lower fertilization rates (55 versus 71%, P, 0.01) and
embryo scores in couples with AZFc microdeletions, overall
pregnancy rates did not differ (39).
Choi et al. (2004) reported their experience with 17 men with
different types of Y chromosome microdeletions. Consistent
with previous reports, they were unable to obtain sperma-
tozoa with TESE in men with complete deletion of AZFa or
AZFb or AZFbc regions.
Spermatozoa were obtained from men with AZFc deficien-
cies and one with partial AZFb deficiency. Patients with Y
chromosome microdeletions were studied in two groups de-
pending on whether TESE or ejaculated spermatozoa was
used. These were compared to matched controls. Although
there was a tendency towards decreased fertilization and
pregnancy rates, the differences were not statistically signifi-
cant (40).
Overall, studies of ART outcome in patients with AZFc dele-
tions suggest a tendency toward decreased fertilization rates
but not a significant change in overall pregnancy and delivery
rates compared to matched controls (38).
4. Discussion
Spermatogenesis is regulated by some of the genes on Y
chromosome and autosome chromosomes. Among chromo-
somal abnormalities, sex chromosomal abnormalities were
more reported in the azoospermia group, while autosomal
abnormalities were more common in the oligospermia group
(41). The Y chromosome is a target for increased genetic
damage. It is reported that the risk of genetic damage to the
Y chromosome increases due to the rapid division of repro-
ductive cells during embryonic and pubertal life (42). YCM
is an important factor in male infertility (43). About 15% of
men with azoospermia and 10-15% of men with oligosper-
mia have YCM. Moreover, since all genes on this chromo-
some are haploid, it seems that defects in one gene can lead
to further defects even if that defect is completed by the pres-
ence of several copies on Y chromosome (42). Ethnic and re-
gional differences are important factors in the diversity and
prevalence of YCM. Phenotypic differences created by dele-
tions of AZF regions can be due to different environmental
influences. The results of studies over the past decade have
shown that most Y chromosome deletions in the AZFc region
occur in 60% of men with infertility (43, 44). In one study,
more than 80% of deletions were observed in the AZFc re-
gion and the rest in the AZFb region, and no deletions were
observed in the AZFa region (45). A recent study showed that
AZFc deletion leads to severe azoospermia or oligospermia
(46). In another study, complete AZFb and AZFb+c deletions
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led to azoospermia (47, 48). Most microparticles occur in the
AZFc region and are associated with reduced sperm produc-
tion to azoospermia (8, 27). The results show that in men
with complete deletions in any of the AZFa, abc, and bc re-
gions, sperm cannot be retrieved from the testis tissue, while
75% of testicular sperm extraction (TESE) cases have been
successful when only the c region was deleted (14).
Also, in a study on infertile men with azoospermia, the high-
est YCM were reported in the AZFb region with a frequency
of 66.67% and in the AZFc region with a frequency of 41.67%
(12). In contrast, no significant deletions in AZF were re-
ported on the Y chromosome of infertile men (9, 27). On the
other hand, in another study on 97 infertile men, no chromo-
some Y microdeletions were seen (49). Some studies have re-
ported AZFc microdeletions in 5% of men, and the total num-
ber of microdeletions were reported to be very low (37, 50).
This difference in the frequency of deletions and deleted
points in different studies may be due to genetic differences
in different populations. In addition, the number of pa-
tients studied, how to select patients according to the sever-
ity of sperm disorder, etiology of spermatogenesis, and cli-
matic differences are effective factors. Moreover, the dif-
ferent primers used in different studies can be effective in
assessing chromosomal microdeletions and the various re-
ported frequencies (51). According to the results of recent
studies, many cases of azoospermia and non-obstructive
oligospermia have a genetic origin. Therefore, it is recom-
mended that male offspring of men with AZF deletions un-
dergo andrological examinations due to the progressive neg-
ative effect of YCM on sperm production during puberty and
preserve their sperm at younger ages before being further
damaged (40). However, these microdeletions cannot be pre-
dicted and identified by clinical findings, age analysis, and
cytological methods. PCR methods based on the identifica-
tion of Y chromosome microdeletions are required for better
diagnosis and patient management (39). According to pre-
vious studies and since the rate of YCM increases with sper-
matogenesis defects, these microdeletions can be the main
.
5. Conclusion
The detection of microdeletions in the AZF region is signif-
icant from a diagnostic viewpoint. Deletions of the AZFa,
AZFb and AZFc regions are associated with abnormal sper-
matogenesis and although certain deletions have a detri-
mental effect on sperm retrieval, the majority of men with
AZFc deletions have no problems during sperm retrieval for
use in ART. In people with AZFa and b deletion, surgery is not
recommend, and for people with AZFc, it is recommended to
freeze sperm. Spermatozoa can be preserved by storing and
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Figure 1: The human Y-chromosome.
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